Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0

Ian Law, Nathalie L. Albert, Javier Arbizu, Ronald Boellaard, Alexander Drzezga, Norbert Galldiks, Christian la Fougère, Karl Josef Langen, Egesta Lopci, Val Lowe, Jonathan McConathy, Harald H. Quick, Bernhard Sattler, David M. Schuster, Jörg Christian Tonn, Michael Weller

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374–80, 2006), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199–208, 2016). The information provided should be taken in the context of local conditions and regulations.

Original languageEnglish (US)
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Molecular Imaging
Nuclear Medicine
Fluorodeoxyglucose F18
Practice Guidelines
Glioma
Joints
Amino Acids
Neuroimaging
Guidelines
Evidence-Based Medicine

Keywords

  • FDG
  • FDOPA
  • FET
  • Glioma
  • MET
  • PET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG : version 1.0. / Law, Ian; Albert, Nathalie L.; Arbizu, Javier; Boellaard, Ronald; Drzezga, Alexander; Galldiks, Norbert; la Fougère, Christian; Langen, Karl Josef; Lopci, Egesta; Lowe, Val; McConathy, Jonathan; Quick, Harald H.; Sattler, Bernhard; Schuster, David M.; Tonn, Jörg Christian; Weller, Michael.

In: European Journal of Nuclear Medicine and Molecular Imaging, 01.01.2018.

Research output: Contribution to journalArticle

Law, I, Albert, NL, Arbizu, J, Boellaard, R, Drzezga, A, Galldiks, N, la Fougère, C, Langen, KJ, Lopci, E, Lowe, V, McConathy, J, Quick, HH, Sattler, B, Schuster, DM, Tonn, JC & Weller, M 2018, 'Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0', European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-018-4207-9
Law, Ian ; Albert, Nathalie L. ; Arbizu, Javier ; Boellaard, Ronald ; Drzezga, Alexander ; Galldiks, Norbert ; la Fougère, Christian ; Langen, Karl Josef ; Lopci, Egesta ; Lowe, Val ; McConathy, Jonathan ; Quick, Harald H. ; Sattler, Bernhard ; Schuster, David M. ; Tonn, Jörg Christian ; Weller, Michael. / Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG : version 1.0. In: European Journal of Nuclear Medicine and Molecular Imaging. 2018.
@article{9ecd1b533919431286aa3b8487d2bd19,
title = "Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0",
abstract = "These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374–80, 2006), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199–208, 2016). The information provided should be taken in the context of local conditions and regulations.",
keywords = "FDG, FDOPA, FET, Glioma, MET, PET",
author = "Ian Law and Albert, {Nathalie L.} and Javier Arbizu and Ronald Boellaard and Alexander Drzezga and Norbert Galldiks and {la Foug{\`e}re}, Christian and Langen, {Karl Josef} and Egesta Lopci and Val Lowe and Jonathan McConathy and Quick, {Harald H.} and Bernhard Sattler and Schuster, {David M.} and Tonn, {J{\"o}rg Christian} and Michael Weller",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s00259-018-4207-9",
language = "English (US)",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG

T2 - version 1.0

AU - Law, Ian

AU - Albert, Nathalie L.

AU - Arbizu, Javier

AU - Boellaard, Ronald

AU - Drzezga, Alexander

AU - Galldiks, Norbert

AU - la Fougère, Christian

AU - Langen, Karl Josef

AU - Lopci, Egesta

AU - Lowe, Val

AU - McConathy, Jonathan

AU - Quick, Harald H.

AU - Sattler, Bernhard

AU - Schuster, David M.

AU - Tonn, Jörg Christian

AU - Weller, Michael

PY - 2018/1/1

Y1 - 2018/1/1

N2 - These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374–80, 2006), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199–208, 2016). The information provided should be taken in the context of local conditions and regulations.

AB - These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374–80, 2006), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199–208, 2016). The information provided should be taken in the context of local conditions and regulations.

KW - FDG

KW - FDOPA

KW - FET

KW - Glioma

KW - MET

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=85058002482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058002482&partnerID=8YFLogxK

U2 - 10.1007/s00259-018-4207-9

DO - 10.1007/s00259-018-4207-9

M3 - Article

C2 - 30519867

AN - SCOPUS:85058002482

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

SN - 1619-7070

ER -